- Home
- BCLI vs MLGO Comparison
BCLI vs MLGO Comparison
Compare BCLI & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- MLGO
- Stock Information
- Founded
- BCLI 2000
- MLGO 2018
- Country
- BCLI United States
- MLGO China
- Employees
- BCLI N/A
- MLGO N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- MLGO EDP Services
- Sector
- BCLI Health Care
- MLGO Technology
- Exchange
- BCLI Nasdaq
- MLGO Nasdaq
- Market Cap
- BCLI 9.9M
- MLGO 16.0M
- IPO Year
- BCLI N/A
- MLGO N/A
- Fundamental
- Price
- BCLI $1.73
- MLGO $6.36
- Analyst Decision
- BCLI Strong Buy
- MLGO
- Analyst Count
- BCLI 1
- MLGO 0
- Target Price
- BCLI $30.00
- MLGO N/A
- AVG Volume (30 Days)
- BCLI 41.1K
- MLGO 32.9M
- Earning Date
- BCLI 03-31-2025
- MLGO 02-28-2025
- Dividend Yield
- BCLI N/A
- MLGO N/A
- EPS Growth
- BCLI N/A
- MLGO N/A
- EPS
- BCLI N/A
- MLGO N/A
- Revenue
- BCLI N/A
- MLGO $83,504,125.00
- Revenue This Year
- BCLI N/A
- MLGO N/A
- Revenue Next Year
- BCLI N/A
- MLGO N/A
- P/E Ratio
- BCLI N/A
- MLGO N/A
- Revenue Growth
- BCLI N/A
- MLGO 643.57
- 52 Week Low
- BCLI $1.05
- MLGO $1.11
- 52 Week High
- BCLI $11.85
- MLGO $509.60
- Technical
- Relative Strength Index (RSI)
- BCLI 40.62
- MLGO 86.06
- Support Level
- BCLI $1.69
- MLGO $1.11
- Resistance Level
- BCLI $1.93
- MLGO $1.34
- Average True Range (ATR)
- BCLI 0.11
- MLGO 0.76
- MACD
- BCLI -0.00
- MLGO 0.35
- Stochastic Oscillator
- BCLI 16.67
- MLGO 49.53
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments Central processing algorithm services & Intelligent chips and services. The majority is from the Central processing algorithm services. which refer to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.